Skip Nav Destination
About the Journal
Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms.. Read More About the Journal
Impact Factor
6.261
Featured Articles
Trending - Altmetric
Nonclinical characterization of bexmarilimab, a Clever-1-targeting antibody for supporting immune defense against cancers
Last mentioned on Monday May 16 2022
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells
Last mentioned on Monday May 16 2022
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms
Last mentioned on Sunday May 15 2022
Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts
Last mentioned on Sunday May 15 2022
Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma
Last mentioned on Sunday May 15 2022